Cas:57486-70-1 Methyl {4-[(methylsulfonyl)amino]phenyl}acetate manufacturer & supplier

Chemical Name:Methyl {4-[(methylsulfonyl)amino]phenyl}acetate

CAS.NO:57486-70-1

Synonyms:Methyl {4-[(methylsulfonyl)amino]phenyl}acetate

Molecular Formula:C₁₀H₁₃NO₄S

Molecular Weight:243.28000

HS Code:2935009090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:80.85000

Exact Mass:243.05700

LogP:1.92740

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Methyl {4-[(methylsulfonyl)amino]phenyl}acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl {4-[(methylsulfonyl)amino]phenyl}acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl {4-[(methylsulfonyl)amino]phenyl}acetate Use and application,Methyl {4-[(methylsulfonyl)amino]phenyl}acetate technical grade,usp/ep/jp grade.

Related News: Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. 4-[[2-chloro-4-[3-chloro-4-[2-(3-methyl-5-oxo-1-phenylpyrazol-4-ylidene)hydrazinyl]phenyl]phenyl]hydrazinylidene]-5-methyl-2-phenylpyrazol-3-one manufacturers Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. 3-(1,5-Dimethyl-hexyl)-3a,5b-dimethyl-2,3,3a,4,5,5a,5b,6,7,9,10,13,13a,13b-tetradecahydro-1H-11-oxa-8-thia-cyclopenta[a]chrysene suppliers MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said. Dichloro-{[1-chloro-1-dimethylamino-meth-(E)-ylidene]-carbamoyl}-acetyl chloride vendor & factory As for argenx’s efgartigimod, that drug hasn’t scored an FDA nod yet and its eventual cost-effectiveness will depend on its price. ,The company’s greenfield facility in Vasanthnarsapura Karnataka Industrial Area, Tumkur district, Karnataka, is under construction and is expected to be commissioned by April, 2022, well before the PLI scheme deadline of April 1, 2023.